These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15345871)

  • 41. Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!
    Vashishtha VM; Ramachandran VG
    Indian Pediatr; 2015 Oct; 52(10):837-9. PubMed ID: 26499003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimated global incidence of Japanese encephalitis: a systematic review.
    Campbell GL; Hills SL; Fischer M; Jacobson JA; Hoke CH; Hombach JM; Marfin AA; Solomon T; Tsai TF; Tsu VD; Ginsburg AS
    Bull World Health Organ; 2011 Oct; 89(10):766-74, 774A-774E. PubMed ID: 22084515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China.
    Yang Y; Liang N; Tan Y; Xie Z
    Int J Infect Dis; 2016 Apr; 45():135-8. PubMed ID: 26972041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
    Hegde NR; Gore MM
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Japanese encephalitis globally and in India.
    Jacobson J; Sivalenka S
    Indian J Public Health; 2004; 48(2):49-56. PubMed ID: 15709584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization.
    Lopez AL; Raguindin PF; Aldaba JG; Avelino F; Sy AK; Heffelfinger JD; Silva MWT
    Int J Infect Dis; 2021 Jan; 102():344-351. PubMed ID: 33127505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
    Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study.
    Tandale BV; Khan SA; Kushwaha KP; Rahman H; Gore MM;
    J Infect Public Health; 2018; 11(5):713-719. PubMed ID: 29703709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of Japanese encephalitis vaccines.
    Hu YL; Lee PI
    Hum Vaccin Immunother; 2021 Nov; 17(11):4259-4264. PubMed ID: 34613870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China.
    Yin Z; Wang H; Yang J; Luo H; Li Y; Hadler SC; Sandhu HS; Fischer M; Jiang Y; Zhang Z; Liu G; Li L; Johnson BW; Liang X;
    Am J Trop Med Hyg; 2010 Oct; 83(4):766-73. PubMed ID: 20889863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(45):898-900. PubMed ID: 24226626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for the use of Japanese encephalitis vaccines.
    Lee PI; Huang YC; Hwang KP; Liu CC; Chiu CH; Chen PY; Lu CY; Chen CJ; Chang LY; Chiu NC; Chi H; Lin HC; Wu KG; Ho YH; Sun W; Lin TY
    Pediatr Neonatol; 2020 Feb; 61(1):3-8. PubMed ID: 31870559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk assessment for Japanese encephalitis vaccination.
    Turtle L; Driver C
    Hum Vaccin Immunother; 2018 Jan; 14(1):213-217. PubMed ID: 29244615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Environmental factors and spatiotemporal distribution of Japanese encephalitis after vaccination campaign in Guizhou Province, China (2004-2016).
    Zhao S; Li Y; Fu S; Liu M; Li F; Liu C; Yu J; Rui L; Wang D; Wang H
    BMC Infect Dis; 2021 Nov; 21(1):1172. PubMed ID: 34809606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital-based surveillance for Japanese encephalitis in Bangladesh, 2007-2016: Implications for introduction of immunization.
    Paul KK; Sazzad HMS; Rahman M; Sultana S; Hossain MJ; Ledermann JP; Burns P; Friedman MS; Flora MS; Fischer M; Hills S; Luby SP; Gurley ES
    Int J Infect Dis; 2020 Oct; 99():69-74. PubMed ID: 32721530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
    Ginsburg AS; Meghani A; Halstead SB; Yaich M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.